RET and pheochromocytoma: The patient carried the RET variant c.2410G>A, p.Val804Met is a well-known activating mutation involved in MEN2A with a moderate risk of MTC and an incidence of pheochromocytoma and primary hyperparathyroidism of less than 10%.